Pharma firms ask for clarity on tariffs under US-EU trade agreement Business July 30, 2025 The U.S.–EU trade agreement sparks uncertainty in the pharmaceutical sector, risking $100 billion in EU investments and disrupting global drug supply chains and innovation.